Skip to main content

ADVERTISEMENT

Robert J. Snyder

Original Research
12/20/2023
Robert J. Snyder
Adam J. Singer
Cyaandi R. Dove
Stephen Heisler
Howard Petusevsky
Garth James
Elinor deLancey Pulcini
Aya Ben Yaakov
Lior Rosenberg
Edward Grant
Yaron Shoham
This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.
This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.
This study examines the efficacy...
12/20/2023
Wounds
Original Research
01/03/2023
Robert J. Snyder
Vickie Driver
Windy Cole
Warren S. Joseph
Alez Reyzelman
John C. Lantis II
Jarrod Kaufman
Thomas Wild
This original research features 4 consensus statements from a panel of wound care experts on the use of topical autologous blood clot therapy to promote healing for a range of wound types.
This original research features 4 consensus statements from a panel of wound care experts on the use of topical autologous blood clot therapy to promote healing for a range of wound types.
This original research features...
01/03/2023
Wounds
Review
07/07/2022
Robert J. Snyder
Vickie Driver
Windy Cole
Warren S. Joseph
Alez Reyzelman
John C. Lantis II
Jarrod Kaufman
Thomas Wild
This publication, the first in a series, provides an evidence basis of the gap between definition and treatment of complex wounds, an overview of the use of autologous therapies in these wounds, and the science behind TABCT.
This publication, the first in a series, provides an evidence basis of the gap between definition and treatment of complex wounds, an overview of the use of autologous therapies in these wounds, and the science behind TABCT.
This publication, the first in a...
07/07/2022
Wounds
RE: A literature review of pharmacological agents to improve venous leg ulcer healing
Letters to the Editor
12/07/2020
Brandon Kitchens
Robert J. Snyder
Cherison A. Cuffy
Dear Drs Melin and Dean: Thank you for your feedback and appreciation toward the publication of our July 2020 article with Wounds1 in your November 2020 Letter to the Editor.2 It was our goal to bring to light the different types of...
Dear Drs Melin and Dean: Thank you for your feedback and appreciation toward the publication of our July 2020 article with Wounds1 in your November 2020 Letter to the Editor.2 It was our goal to bring to light the different types of...
Dear Drs Melin and...
12/07/2020
Wounds
Review
07/01/2020
Brandon P. Kitchens
Robert J. Snyder
Cherison Cuffy
This literature review focuses on the efficacy of pharmacological agents, quality of life using agents in addition to compression therapy, and cost effectiveness to indicate the best outcomes for pharmacological treatment of venous leg ulcers.
This literature review focuses on the efficacy of pharmacological agents, quality of life using agents in addition to compression therapy, and cost effectiveness to indicate the best outcomes for pharmacological treatment of venous leg ulcers.
This literature review focuses...
07/01/2020
Wounds
Case Series
08/01/2018
Joey Karim Ead
Robert J. Snyder
Jaime Wise
Cherison Cuffy
Hamed Jafary
Karen Fischborn
Two cases are presented that demonstrate the paradigmatic clinical features of PASH syndrome and its potential link as an expanding spectrum of bacterial biofilm disorder.
Two cases are presented that demonstrate the paradigmatic clinical features of PASH syndrome and its potential link as an expanding spectrum of bacterial biofilm disorder.
Two cases are presented that...
08/01/2018
Wounds
Original Research
07/02/2018
Robert J. Snyder
Maria A. Kasper
Keyur Patel
Marissa J. Carter
Igal Kushnir
Alon Kushnir
Thomas E. Serena
This pilot study evaluates safety in terms of the occurrence of adverse events (AEs) as well as the efficacy in terms of complete wound healing rates of a blood clot product when applied to chronic neuropathic diabetic foot ulcers (DFUs).
This pilot study evaluates safety in terms of the occurrence of adverse events (AEs) as well as the efficacy in terms of complete wound healing rates of a blood clot product when applied to chronic neuropathic diabetic foot ulcers (DFUs).
This pilot study evaluates...
07/02/2018
Wounds
Current Research
02/09/2017
Abdulaziz A. Kimawi
Robert J. Snyder
Mario A. Cala
Cherison Cuffy
02/09/2017
Wounds
Original Research
03/04/2016
Robert J. Snyder
Kenneth Shimozaki
Arthur Tallis
Michael Kerzner
Alexander Reyzelman
Dimitrios Lintzeris
Desmond Bell
Randi L. Rutan
Barry Rosenblum
03/04/2016
Wounds
Letters to the Editor
06/16/2015
Wounds